TELA Bio, Inc. Common Stock
TELA US8723811084
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -16% | -16% | -42% | -54% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Koblish Antony CEO |
2.25 USD |
88,888 Bought |
199,998 USD |
24/10/2024 | 24/10/2024 |
| Cuca Roberto COO |
2.25 USD |
64,444 Bought |
144,999 USD |
24/10/2024 | 24/10/2024 |
| Talmo Paul CTO |
2.25 USD |
22,222 Bought |
50,000 USD |
24/10/2024 | 24/10/2024 |
| Firestone Gregory A. CCO |
2.25 USD |
6,666 Bought |
14,999 USD |
24/10/2024 | 24/10/2024 |
| Firestone Gregory A. CBO |
5.65 USD |
2,600 Bought |
14,688 USD |
05/12/2023 | 05/12/2023 |
| Cuca Roberto COO |
4.49 USD |
10,000 Bought |
44,938 USD |
14/11/2023 | 14/11/2023 |
| Koblish Antony CEO |
4.54 USD |
11,000 Bought |
49,976 USD |
14/11/2023 | 14/11/2023 |